Antibodies targeting the transferrin receptor 1 (TfR1) as direct anti-cancer agents

PV Candelaria, LS Leoh, ML Penichet… - Frontiers in …, 2021 - frontiersin.org
The transferrin receptor 1 (TfR1), also known as cluster of differentiation 71 (CD71), is a type
II transmembrane glycoprotein that binds transferrin (Tf) and performs a critical role in …

Vitamin D: effect on haematopoiesis and immune system and clinical applications

M Medrano, E Carrillo-Cruz, I Montero… - International journal of …, 2018 - mdpi.com
Vitamin D is a steroid-like hormone which acts by binding to vitamin D receptor (VDR). It
plays a main role in the calcium homeostasis and metabolism. In addition, vitamin D display …

[HTML][HTML] Inhibition of endosteal vascular niche remodeling rescues hematopoietic stem cell loss in AML

D Duarte, ED Hawkins, O Akinduro, H Ang… - Cell stem cell, 2018 - cell.com
Bone marrow vascular niches sustain hematopoietic stem cells (HSCs) and are drastically
remodeled in leukemia to support pathological functions. Acute myeloid leukemia (AML) …

The microbiota regulates hematopoietic stem cell fate decisions by controlling iron availability in bone marrow

D Zhang, X Gao, H Li, DK Borger, Q Wei, E Yang, C Xu… - Cell Stem Cell, 2022 - cell.com
Host microbiota crosstalk is essential for the production and functional modulation of blood-
cell lineages. Whether, and if so how, the microbiota influences hematopoietic stem cells …

Differentiation therapy revisited

H de Thé - Nature Reviews Cancer, 2018 - nature.com
The concept of differentiation therapy emerged from the fact that hormones or cytokines may
promote differentiation ex vivo, thereby irreversibly changing the phenotype of cancer cells …

Transition metal chelators, pro-chelators, and ionophores as small molecule cancer chemotherapeutic agents

A Steinbrueck, AC Sedgwick, JT Brewster… - Chemical Society …, 2020 - pubs.rsc.org
Cancer is among the leading causes of death worldwide. Although a number of new
treatment options have been developed in recent years, there remains a need for improved …

IDH1 (R132H) mutation increases murine haematopoietic progenitors and alters epigenetics

M Sasaki, CB Knobbe, JC Munger, EF Lind, D Brenner… - Nature, 2012 - nature.com
Mutations in the IDH1 and IDH2 genes encoding isocitrate dehydrogenases are frequently
found in human glioblastomas and cytogenetically normal acute myeloid leukaemias (AML) …

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia

L Willems, N Jacque, A Jacquel… - Blood, The Journal …, 2013 - ashpublications.org
Cancer cells require nutrients and energy to adapt to increased biosynthetic activity, and
protein synthesis inhibition downstream of mammalian target of rapamycin complex 1 …

Iron and leukemia: new insights for future treatments

F Wang, H Lv, B Zhao, L Zhou, S Wang, J Luo… - Journal of Experimental …, 2019 - Springer
Iron, an indispensable element for life, is involved in all kinds of important physiological
activities. Iron promotes cell growth and proliferation, but it also causes oxidative stress …

PML/RARA oxidation and arsenic binding initiate the antileukemia response of As2O3

M Jeanne, V Lallemand-Breitenbach, O Ferhi, M Koken… - Cancer cell, 2010 - cell.com
As 2 O 3 cures acute promyelocytic leukemia (APL) by initiating PML/RARA oncoprotein
degradation, through sumoylation of its PML moiety. However, how As 2 O 3 initiates PML …